InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by MCLAUGHLIN KEVIN F, Director. Officer active across 2 companies, notably Vericel Corp. In total, 9 disclosures have been published. The latest transaction was filed on 13 May 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€7,8573,500 shares@ €2.24480.0005% mcap33.7% of flow
Common Stock
SEC:0001140361-26-021656·
€7,8573,500 shares@ €2.24480.0005% mcap16.8% of flow
Common Stock
SEC:0001140361-26-021656:0·
US$15,4847,000 shares@ US$2.2120.0009% mcap66.3% of flow
Common Stock
SEC:0001140361-26-005417·
€15,4847,000 shares@ €2.2120.0009% mcap33.2% of flow
Common Stock
SEC:0001140361-26-005417:0·
2,600 shares
Common Stock
SEC:0001593968-22-000890:0·
10,681 shares
Common Stock
SEC:0001104659-21-142266·
10,681 shares
Common Stock
SEC:0001104659-21-142266:0·
€64,2452,500 shares@ €25.6979100.0% of flow
Common Stock
SEC:0001179110-21-008935·
€64,2452,500 shares@ €25.697950.0% of flow
Common Stock
SEC:0001179110-21-008935:0·
9 of 9 declarations
About MCLAUGHLIN KEVIN F
Kevin F. McLaughlin is a Director and Senior Vice President, Chief Financial Officer, and Treasurer at Vericel Corp and Acceleron Pharma Inc. He contributes to the governance of the companies and financial management. McLaughlin brings valuable expertise in the biopharmaceutical sector.
